Merck to acquire Verona Pharma for $10 billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- US stock futures tumble as Trump says Iran deal is 'over', oil climbs
- Oil jumps over 5% to two-week high after Trump says deal with Iran 'over'
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
Morgan Stanley Reiterates Equalweight Rating on Merck (MRK)
July 10, 2025 7:43 AM EDTMorgan Stanley analyst Terrance Flynn reiterated an Equalweight rating and $99.00 price target on Merck (NYSE: MRK).
The analyst comments "Financials: The transaction is expected to close in 4Q25 and will result in the capitalization of most of the purchase price as an... More
